Short interest in Viridian Therapeutics Inc (NASDAQ:VRDN) increased during the last reporting period, rising from 9.79M to 10.02M. This put 14.98% of the company's publicly available shares short.

Short interest for Viridian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Viridian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 711.39K shares traded per day, it would take 14.09 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.